Transplantation of fetal-derived cells for neurological disorders

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Both literature and our own data addressed to transplanting fetal-derived cells for neurologic disorders are reviewed in this paper. According these data, the transplantation of the cells derived from nervous and hemopoietic tissues may be an effective treatment for consequences of craniocerebral trauma, cerebral stroke, spinal cord injury, neuroinfection and of cerebral palsy. The predominant role in the formation of therapeutic effects is assumed to belong to neurotrophic factors being released by grafted cells in the brain injury lessions.

Full Text

Restricted Access

About the authors

G. V. Seiedtsova

Institute of clinical immunology SB RAMS

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Novosibirsk

V. I. Seledtsov

Institute of clinical immunology SB RAMS

Email: info@eco-vector.com
Russian Federation, Novosibirsk

S. S. Rabinovich

Institute of travmatology and orthopedy

Email: info@eco-vector.com
Russian Federation, Novosibirsk

O. V. Parluk

City clinical hospital № 34

Email: info@eco-vector.com
Russian Federation, Novosibirsk

M. Yu. Kafanova

Children’s clinical hospital № 1

Email: info@eco-vector.com
Russian Federation, Novosibirsk

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies